Ophthalmic drugs monograph
This article was originally published in The Tan Sheet
Executive Summary
FDA is updating its OTC ophthalmic drug products final monograph "to be consistent with" USP name change for active ingredient hydroxypropyl methylcellulose that took effect in September 2002, agency says in 1June 3 Federal Register notice. New name for active ingredient is hypromellose, FDA notes. Manufacturers of OTC ophthalmic drug products will have until Sept. 1 to implement labeling changes, agency adds...